Activity-based protein profiling: the serine hydrolases.

With the postgenome era rapidly approaching, new strategies for the functional analysis of proteins are needed. To date, proteomics efforts have primarily been confined to recording variations in protein level rather than activity. The ability to profile classes of proteins on the basis of changes in their activity would greatly accelerate both the assignment of protein function and the identification of potential pharmaceutical targets. Here, we describe the chemical synthesis and utility of an active-site directed probe for visualizing dynamics in the expression and function of an entire enzyme family, the serine hydrolases. By reacting this probe, a biotinylated fluorophosphonate referred to as FP-biotin, with crude tissue extracts, we quickly and with high sensitivity detect numerous serine hydrolases, many of which display tissue-restricted patterns of expression. Additionally, we show that FP-biotin labels these proteins in an activity-dependent manner that can be followed kinetically, offering a powerful means to monitor dynamics simultaneously in both protein function and expression.

[1]  B. Cravatt,et al.  Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism. , 1999, Biochemistry.

[2]  J. Oesterling,et al.  Prostate specific antigen: a decade of discovery--what we have learned and where we are going. , 1999, The Journal of urology.

[3]  B. Cravatt,et al.  Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. , 1999, Biochemistry.

[4]  S. Yoshida,et al.  Plasticity-related serine proteases in the brain (review). , 1999, International journal of molecular medicine.

[5]  L. Hood,et al.  Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Alan Dove,et al.  Proteomics: translating genomics into products? , 1999, Nature Biotechnology.

[7]  P. Kitos,et al.  Identification of serine esterases in tissue homogenates. , 1999, Analytical biochemistry.

[8]  P. Chaurand,et al.  Peptide and protein identification by matrix-assisted laser desorption ionization (MALDI) and MALDI-post-source decay time-of-flight mass spectrometry , 1999, Journal of the American Society for Mass Spectrometry.

[9]  G. J. Kato Human genetic diseases of proteolysis , 1999, Human mutation.

[10]  B. Cravatt,et al.  Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. , 1998, Biochemistry.

[11]  R. Morris,et al.  Serine Proteases in Rodent Hippocampus* , 1998, The Journal of Biological Chemistry.

[12]  N. Anderson,et al.  Proteome and proteomics: New technologies, new concepts, and new words , 1998, Electrophoresis.

[13]  D. Schriemer,et al.  MALDI mass spectrometry combined with avidin-biotin chemistry for analysis of protein modifications. , 1998, Analytical chemistry.

[14]  P. James,et al.  Protein identification in the post-genome era: the rapid rise of proteomics , 1997, Quarterly Reviews of Biophysics.

[15]  N. Seidah,et al.  Eukaryotic protein processing: endoproteolysis of precursor proteins. , 1997, Current opinion in biotechnology.

[16]  Marc R. Wilkins,et al.  Proteome Research: New Frontiers in Functional Genomics , 1997, Principles and Practice.

[17]  A. Goldberg,et al.  Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Dodt,et al.  Identification of the 170-kDa Melanoma Membrane-bound Gelatinase (Seprase) as a Serine Integral Membrane Protease* , 1997, The Journal of Biological Chemistry.

[19]  B. Cravatt,et al.  Molecular characterization of human and mouse fatty acid amide hydrolases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Deutsch,et al.  Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. , 1997, Biochemical pharmacology.

[21]  W. Schill,et al.  Protease-protease inhibitor interactions in Sertoli cell-germ cell crosstalk. , 1997, Advances in experimental medicine and biology.

[22]  Y. DeClerck,et al.  Proteases and protease inhibitors in tumor progression. , 1997, Advances in experimental medicine and biology.

[23]  K. Mann,et al.  The regulation of clotting factors. , 1997, Critical reviews in eukaryotic gene expression.

[24]  N. Nomura,et al.  Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro. , 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

[25]  Stephen P. Mayfield,et al.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides , 1996, Nature.

[26]  J. Trapani,et al.  Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies , 1996, Journal of leukocyte biology.

[27]  E. M. Southard-Smith,et al.  Disparate Tissue-specific Expression of Members of the Tissue Kallikrein Multigene Family of the Rat* , 1996, The Journal of Biological Chemistry.

[28]  J. Powers,et al.  Characterization, application and potential uses of biotin-tagged inhibitors for lymphocyte serine proteases (granzymes). , 1996, Molecular immunology.

[29]  D. Rifkin,et al.  Plasminogen activators and matrix metalloproteinases in angiogenesis. , 1996, Enzyme & protein.

[30]  J. D. Clark,et al.  Cytosolic phospholipase A2. , 1995, Journal of lipid mediators and cell signalling.

[31]  P. Hand,et al.  The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line. , 1995, Cancer research.

[32]  T. Yoshimoto,et al.  Protease II from Moraxella lacunata: cloning, sequencing, and expression of the enzyme gene, and crystallization of the expressed enzyme. , 1995, Journal of biochemistry.

[33]  J. Schlom,et al.  Generation, purification, and characterization of a recombinant source of human prostate‐specific antigen , 1995, Journal of clinical laboratory analysis.

[34]  P. Glynn,et al.  Synthesis and characterization of a biotinylated organophosphorus ester for detection and affinity purification of a brain serine esterase: neuropathy target esterase. , 1994, The Biochemical journal.

[35]  J. Powers,et al.  Biotinylated isocoumarins, new inhibitors and reagents for detection, localization, and isolation of serine proteases. , 1993, Bioconjugate chemistry.

[36]  L. R. Manning,et al.  Acylpeptide hydrolase: inhibitors and some active site residues of the human enzyme. , 1992, The Journal of biological chemistry.

[37]  J. Smith,et al.  Cloning and sequence analysis of a rat liver cDNA encoding acyl-peptide hydrolase. , 1989, The Journal of biological chemistry.

[38]  V. Martín,et al.  A greatly improved procedure for ruthenium tetroxide catalyzed oxidations of organic compounds , 1981 .

[39]  C. Walsh,et al.  Enzymatic Reaction Mechanisms , 1978 .